PEREGRINE PHARMACEUTICALS INC 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Apr 28, 2017
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Other
Common Stock
2017-04-28$0.27/sh+37,389$10,140→ 184,038 total
Footnotes (1)
- [F1]Shares acquired under the issuer's employee stock purchase plan on April 28, 2017